Halperin SA - Search Results

1

Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age.

Halperin SA, Ward B, Cooper C, Predy G, Diaz-Mitoma F, Dionne M, Embree J, McGeer A, Zickler P, Moltz KH, Martz R, Meyer I, McNeil S, Langley JM, Martins E, Heyward WL, Martin JT. Halperin SA, et al. Vaccine. 2012 Mar 28;30(15):2556-63. doi: 10.1016/j.vaccine.2012.01.087. Epub 2012 Feb 9. Vaccine. 2012. PMID: 22326642 Clinical Trial.

2

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children.

Halperin SA, Smith B, Mabrouk T, Germain M, Trépanier P, Hassell T, Treanor J, Gauthier R, Mills EL. Halperin SA, et al. Vaccine. 2002 Jan 15;20(7-8):1240-7. doi: 10.1016/s0264-410x(01)00428-5. Vaccine. 2002. PMID: 11803087 Clinical Trial.

3

Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine.

Halperin SA, Scheifele D, Mills E, Guasparini R, Humphreys G, Barreto L, Smith B. Halperin SA, et al. Vaccine. 2003 Jun 2;21(19-20):2298-306. doi: 10.1016/s0264-410x(03)00173-7. Vaccine. 2003. PMID: 12744860 Clinical Trial.

4

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant.

Halperin SA, Van Nest G, Smith B, Abtahi S, Whiley H, Eiden JJ. Halperin SA, et al. Vaccine. 2003 Jun 2;21(19-20):2461-7. doi: 10.1016/s0264-410x(03)00045-8. Vaccine. 2003. PMID: 12744879 Clinical Trial.

5

Safety and immunoenhancing effect of a Chlorella-derived dietary supplement in healthy adults undergoing influenza vaccination: randomized, double-blind, placebo-controlled trial.

Halperin SA, Smith B, Nolan C, Shay J, Kralovec J. Halperin SA, et al. CMAJ. 2003 Jul 22;169(2):111-7. CMAJ. 2003. PMID: 12874157 Free PMC article. Clinical Trial.

6

A pilot study to quantify parental anxiety associated with enrollment of an infant or toddler in a phase III vaccine trial.

Langley JM, Halperin SA, Smith B. Langley JM, et al. Among authors: halperin sa. Vaccine. 2003 Sep 8;21(25-26):3863-6. doi: 10.1016/s0264-410x(03)00304-9. Vaccine. 2003. PMID: 12922120 Clinical Trial.

7

Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.

Langley JM, Halperin SA, Boucher FD, Smith B; Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC). Langley JM, et al. Among authors: halperin sa. Pediatrics. 2004 Jul;114(1):e96-101. doi: 10.1542/peds.114.1.e96. Pediatrics. 2004. PMID: 15231980 Clinical Trial.

8

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.

McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, Baxendale DM, Reddish MA, Hu MC, Stroop SD, Linden J, Fries LF, Vink PE, Dale JB. McNeil SA, et al. Among authors: halperin sa. Clin Infect Dis. 2005 Oct 15;41(8):1114-22. doi: 10.1086/444458. Epub 2005 Sep 12. Clin Infect Dis. 2005. PMID: 16163629 Clinical Trial.

9

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults.

Halperin SA, Dobson S, McNeil S, Langley JM, Smith B, McCall-Sani R, Levitt D, Nest GV, Gennevois D, Eiden JJ. Halperin SA, et al. Vaccine. 2006 Jan 9;24(1):20-6. doi: 10.1016/j.vaccine.2005.08.095. Epub 2005 Sep 12. Vaccine. 2006. PMID: 16198027 Clinical Trial.

10

Safety and immunogenicity of a Proteosome -trivalent inactivated influenza vaccine, given nasally to healthy adults.

Langley JM, Halperin SA, McNeil S, Smith B, Jones T, Burt D, Mallett CP, Lowell GH, Fries L. Langley JM, et al. Among authors: halperin sa. Vaccine. 2006 Mar 6;24(10):1601-8. doi: 10.1016/j.vaccine.2005.09.056. Epub 2005 Oct 14. Vaccine. 2006. PMID: 16303215 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

374 results

Search Page